Immediate Clinical Success After Percutaneous Ablation of Extra-adrenal Paraganglioma
- 146 Downloads
Paragangliomas (PGLs) are catecholamine-secreting neoplasms of chromaffin cells and represent a rare but curable cause of secondary hypertension. Surgery is the treatment of choice for symptomatic PGLs. A small (7 mm) extra-adrenal PGL was diagnosed in the right retroperitoneal space in a 19-year-old patient affected by symptomatic hypertension unresponsive to medical treatment. Indication to percutaneous radiofrequency ablation (RFA) was given by a multidisciplinary team on the basis of the size of the nodule, the surgical risks, the young age of the patient, and his wish to reduce as much as possible the post-interventional rehabilitation. To our knowledge, the use of percutaneous RFA in the treatment of retroperitoneal extra-adrenal primary paragangliomas has never been described. We describe its feasibility and the patient’s clinical outcome.
KeywordsParaganglioma Percutaneous radiofrequency ablation Hypertension
This study was not supported by any funding.
Compliance with Ethical Standards
Conflict of interest
The authors declare that they have no conflict of interest.
The procedure performed in the study involving human participant was in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from the patient included in the study.
Consent for Publication
Consent for publication was obtained for the patient’s personal data included in the study.
- 4.Carrafiello G, Laganà D, Recaldini C, Giorgianni A, Ianniello A, Lumia D, D’Ambrosio A, Petullà M, Dionigi G, Fugazzola C. Imaging-guided percutaneous radiofrequency ablation of adrenal metastases: preliminary results at a single institution with a single device. Cardiovasc Intervent Radiol. 2008;31:762–7.CrossRefGoogle Scholar